Anavex to discuss pediatric inclusion in Phase 3 Rett trial
Anavex said the FDA granted a meeting to discuss including pediatric patients in its Phase 3 Rett syndrome trial for ANAVEX 2-73.
Key Highlights:Original SEC Filing: ANAVEX LIFE SCIENCES CORP. [ AVXL ] - 8-K - Sep. 09, 2026This is an AI-powered summary. It may contain inaccuracies.
Consider…